Transaction DateRecipientSharesTypePriceValue
19th January 2021Richard B Stone20,000Grant/award etc.$0.00
19th January 2021Dennis Matheis17,620Grant/award etc.$0.00
19th January 2021Hila Karah20,147Grant/award etc.$0.00
19th January 2021Erez Raphael413,158Grant/award etc.$0.00
19th January 2021Yoav Shaked16,609Grant/award etc.$0.00
19th January 2021Dennis M Mcgrath29,616Grant/award etc.$0.00
19th January 2021Zvi Ben David111,228Grant/award etc.$0.00
19th January 2021Zvi Ben David1,152Grant/award etc.$0.00
19th January 2021Erez Raphael2,268Open or private purchase$0.00
19th January 2021Adam K Stern43,850Open or private purchase$0.00
Dario Health
Dario Health logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.


DarioHealth Corp. engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011.


Ticker: DRIO
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1533998
Employees: 72
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals